Consultation on process for selecting NICE technology appraisal topics
A consultation is underway on some proposed changes to the way that technology appraisal topics are selected for referral to NICE.
Welcoming the consultation, Andrew Dillon, Chief Executive of NICE, said:
“This is an important consultation on the way that topics are chosen and referred for NICE's world-leading appraisals of new drugs and treatments. We are very keen to ensure that our guidance is produced as quickly as possible to benefit patients and the NHS.
“Speeding up non-cancer appraisals by at least three months to come in to line with the cancer appraisals, and increasing transparency by clarifying topic selection criteria, are just some of the potential improvements we and the Department of Health are suggesting.
“The views of patients, the public, health professionals and other stakeholders on the proposed changes to the topic selection process will be very helpful, and we look forward to receiving their comments.”
This page was last updated: 09 March 2009